Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Apr 30;13(4):622-625.
doi: 10.21037/tau-23-603. Epub 2024 Apr 9.

European association of urology biochemical recurrence risk stratification in the context of post-prostatectomy salvage therapy

Timothy A Lin  1 , Daniel Y Song  1
Affiliations
Editorial

European association of urology biochemical recurrence risk stratification in the context of post-prostatectomy salvage therapy

Timothy A Lin et al. Transl Androl Urol. .
No abstract available

Keywords: Salvage radiation therapy; biochemical recurrence (BCR); prostate cancer.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: Both authors have completed the ICMJE uniform disclosure form (available at https://tau.amegroups.com/article/view/10.21037/tau-23-603/coif). The authors have no conflicts of interest to declare.

Comment on

References

    1. Trock BJ, Han M, Freedland SJ, et al. Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy. JAMA 2008;299:2760-9. 10.1001/jama.299.23.2760 - DOI - PMC - PubMed
    1. Kneebone A, Fraser-Browne C, Duchesne GM, et al. Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trial. Lancet Oncol 2020;21:1331-40. 10.1016/S1470-2045(20)30456-3 - DOI - PubMed
    1. Parker CC, Clarke NW, Cook AD, et al. Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trial. Lancet 2020;396:1413-21. 10.1016/S0140-6736(20)31553-1 - DOI - PMC - PubMed
    1. Sargos P, Chabaud S, Latorzeff I, et al. Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical prostatectomy (GETUG-AFU 17): a randomised, phase 3 trial. Lancet Oncol 2020;21:1341-52. 10.1016/S1470-2045(20)30454-X - DOI - PubMed
    1. Preisser F, Abrams-Pompe RS, Stelwagen PJ, et al. European Association of Urology Biochemical Recurrence Risk Classification as a Decision Tool for Salvage Radiotherapy-A Multicenter Study. Eur Urol 2024;85:164-70. 10.1016/j.eururo.2023.05.038 - DOI - PubMed